Bombay HC in favor of Natco\’s Compulsory License
Recently, Bombay High Court supported the Granted compulsory license to Indian pharma company Natco for the sale of a generic version of Bayer’s anti-cancer drug Nexavar. With this decision, Natco will now be legally able to manufacture and sell the generic copy of sorafenib tosylate, a patented kidney cancer drug invented by German Pharma giant …
Bombay HC in favor of Natco\’s Compulsory License Read More »
